Balyasny Asset Management’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-281,107
Closed -$15.8K 2252
2023
Q1
$15.8K Hold
281,107
﹤0.01% 2028
2022
Q4
$16.7K Hold
281,107
﹤0.01% 2059
2022
Q3
$18K Hold
281,107
﹤0.01% 2105
2022
Q2
$42K Hold
281,107
﹤0.01% 1940
2022
Q1
$129K Hold
281,107
﹤0.01% 1751
2021
Q4
$503K Sell
281,107
-18,893
-6% -$33.8K ﹤0.01% 1394
2021
Q3
$270K Buy
+300,000
New +$270K ﹤0.01% 1356